MagicMed Industries Announces Agreements with the University of Calgary to Accelerate Development of the MagicMed Psybrary™
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Ryan Allway October 29th, 2020 News, Top News DENVER, Oct. 28, 2020 /PRNewswire/ — Akerna Corp. (Nasdaq: KERN), (“Akerna” or the “Company”), a leading compliance technology provider and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), today announced it has priced a public offering of 5,000,000... Read more
Thrive Agritech Receives High Volume Order from Native Roots Cannabis Co.
Ryan Allway October 27th, 2020 News, Top News Thrive Agritech, Inc., leader in LED horticulture lighting, announced today that it has received orders from Native Roots Cannabis Co. for more than 1,500 of its high-performance LED light fixtures. Thrive Agritech’s Infinity 2.0 LED lights were installed in multi-tier vegetative... Read more
Grand View Research Collaborates With Cannyx Markets, To Deliver World-class Cannabinoid Industry Intelligence Platform
Ryan Allway October 27th, 2020 News, Top News  Grand View Research, a leading US-based market research provider and Cannyx Corporation Ltd, owner of Cannyx Markets an online real-time trading venue and market data service platform for organic and non-GMO certified hemp and non-medicinal based cannabinoids, have announced a collaboration that will create a... Read more
Jazz Pharmaceuticals Acquires SpringWorks Therapeutics’ FAAH Inhibitor Program
Ryan Allway October 27th, 2020 News, Top News Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) (“SpringWorks”) today announced that Jazz Pharmaceuticals Ireland Limited (“Jazz”) and SpringWorks have entered into an asset purchase and exclusive license agreement under which Jazz has acquired SpringWorks’ fatty acid amide hydrolase (“FAAH”)... Read more
BevCanna is currently in late-stage discussions to partner with a leading Canadian Licensed Producer (“LP”) to distribute its products to provincial cannabis distribution boards through the LP’s Health Canada issued Sales License. This will allow BevCanna to begin distribution of its white-label client products, Keef & Cali-Bloom branded products... Read more
TORONTO, Oct. 26, 2020 /CNW/ – Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the “Company” or “Canntab“), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the impending launch of its suite of hard pill cannabinoid formulations in Australia with its partner... Read more
Ryan Allway October 26th, 2020 News, Top News Abba Medix Corp. to distribute Rubicon Organics’ concentrate products through existing provincial distribution channels TORONTO, Oct. 26, 2020 /CNW/ – Canada House Wellness Group (CSE: CHV) (“Canada House” or the “Company“), a fully integrated medical cannabis company, is pleased to announce that it has entered... Read more
Rubicon Organics Establishes Route to Market for Cannabis 2.0 Products
Ryan Allway October 26th, 2020 News, Top News Rubicon Organics signs distribution agreement with Canada House Wellness Group to sell concentrate products to provincial distributors VANCOUVER, British Columbia, Oct. 26, 2020 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer... Read more
Hyasynth completes key commercialization milestone for cannabinoid biosynthesis, receives $2.5 million payment
Ryan Allway October 23rd, 2020 News, Top News Hyasynth receives $2.5 million milestone payment following first-to-market achievement with CBD produced by fermentation MONTREAL, Oct. 23, 2020 /PRNewswire/ – Hyasynth, a sustainable biotechnology company, has received a $2.5M milestone payment for its commercialization achievements in being first-to-market with cannabidiol (CBD) produced and extracted from yeast. The... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )